Université Paris-Diderot & Inserm, UMR1123, Patient-Centered Outcomes Research, Paris, France.
Hôpital Bicêtre, Service d'infectiologie, Le Kremlin Bicêtre, France.
PLoS One. 2020 Jun 26;15(6):e0235260. doi: 10.1371/journal.pone.0235260. eCollection 2020.
The prevalence of HIV, hepatitis B, and hepatitis C amongst migrants in France is high. Thus, effective screening and follow-up is needed. The mandatory medical check-up for residency application is an opportunity to offer rapid HIV and hepatitis testing. The main objective of the STRADA study is to create a feasible and acceptable screening strategy for migrants. Within the STRADA study, this qualitative research examined the acceptability of conducting screening tests in the context of residency application.
We conducted a qualitative study amongst legal migrants over 18 years of age with sufficient knowledge of the French, English, or Arabic language. Interviews were performed following a semi-structured interview guide of open-ended questions. Interviews were transcribed verbatim and subsequently analyzed through thematic analysis.
We interviewed 34 migrants. Mean age was 32.6 (min-max: 19, 59) years. The participants' region of origin was mostly Sub-Saharan Africa and the main reason for migrating to France was family reunification. Migrants' acceptability of HIV and hepatitis testing was high. Participants who accepted testing indicated a benefit for individual health and to avoid transmission. Most preferred rapid tests; reluctance was related to anxiety about the immediate results and the perceived reliability of rapid tests. Migrants' knowledge about HIV was satisfactory, but inadequate for hepatitis. Screening in the context of a compulsory medical visit did not present an obstacle for acceptability. Some expressed concern in the case of HIV but when explained, the independence between obtaining the residence permit along with screening and access to medical care was well understood.
Medical check-ups at immigration centers is an opportunity to screen for HIV and hepatitis which is considered acceptable by migrants. Informing migrants that test results do not affect residency applications, and incorporating their preferences, are all important to optimize the acceptability of screening.
法国移民中艾滋病毒、乙型肝炎和丙型肝炎的流行率很高。因此，需要进行有效的筛查和随访。申请居留的强制性体检是提供快速艾滋病毒和肝炎检测的机会。STRADA 研究的主要目的是为移民创建一种可行且可接受的筛查策略。在 STRADA 研究中，这项定性研究考察了在居留申请背景下进行筛查测试的可接受性。
我们对年龄在 18 岁以上、具有足够的法语、英语或阿拉伯语知识的合法移民进行了定性研究。访谈采用半结构化访谈指南进行，问题为开放式。访谈内容逐字记录下来，然后通过主题分析进行分析。
我们采访了 34 名移民。平均年龄为 32.6 岁（最小-最大：19 岁，59 岁）。参与者原籍地区主要来自撒哈拉以南非洲，移民法国的主要原因是家庭团聚。移民对艾滋病毒和肝炎检测的可接受性很高。接受检测的参与者表示，这对个人健康和避免传播有益。大多数人更喜欢快速检测；不愿意进行检测与对即时结果的焦虑和对快速检测可靠性的感知有关。移民对艾滋病毒的了解令人满意，但对肝炎的了解不足。在强制性体检背景下进行筛查并不影响可接受性。有些人对艾滋病毒表示担忧，但在解释后，他们理解居留许可申请与筛查和获得医疗保健的独立性。
移民中心的体检是筛查艾滋病毒和肝炎的机会，被移民认为是可以接受的。告知移民测试结果不影响居留许可申请，并纳入他们的偏好，对于优化筛查的可接受性非常重要。
